We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDC icon
1176
Belden
BDC
$5.01B
$47K ﹤0.01%
670
-3,728
-85% -$259K
DTE icon
1177
DTE Energy
DTE
$29.1B
$47K ﹤0.01%
586
-3,820
-87% -$311K
GBF icon
1178
iShares Government/Credit Bond ETF
GBF
$128M
$47K ﹤0.01%
+400
New +$47K
HUM icon
1179
Humana
HUM
$43.7B
$47K ﹤0.01%
267
+156
+141% +$27.1K
IXJ icon
1180
iShares Global Healthcare ETF
IXJ
$4.13B
$47K ﹤0.01%
+926
New +$47.6K
MDT icon
1181
Medtronic
MDT
$110B
$47K ﹤0.01%
545
-23,872
-98% -$2.08M
MSA icon
1182
Mine Safety
MSA
$7.44B
$47K ﹤0.01%
812
-1,274
-61% -$71.2K
PEO
1183
Adams Natural Resources Fund
PEO
$721M
$47K ﹤0.01%
+2,466
New +$46.8K
UE icon
1184
Urban Edge Properties
UE
$2.78B
$47K ﹤0.01%
1,679
-6,724
-80% -$195K
WHLR
1185
Wheeler Real Estate Investment Trust
WHLR
$481K
0
TVRD
1186
Tvardi Therapeutics
TVRD
$25M
$47K ﹤0.01%
+158
New +$34.2K
GNC
1187
DELISTED
GNC Holdings, Inc.
GNC
$47K ﹤0.01%
2,307
-1,469
-39% -$32.2K
ACET
1188
DELISTED
Aceto Corp
ACET
$47K ﹤0.01%
2,491
+247
+11% +$5.59K
FSAM
1189
DELISTED
Fifth Street Asset Management Inc. Class A
FSAM
$47K ﹤0.01%
8,678
+8,478
+4,239% +$41.6K
WBMD
1190
DELISTED
WebMD Health Corp.
WBMD
$47K ﹤0.01%
949
-2,604
-73% -$144K
BOXC
1191
DELISTED
Brookfield Can Office Properties
BOXC
$47K ﹤0.01%
2,240
+1,440
+180% +$31.5K
EHC icon
1192
Encompass Health
EHC
$11B
$46K ﹤0.01%
1,413
-4,856
-77% -$157K
G icon
1193
Genpact
G
$6.07B
$46K ﹤0.01%
+1,895
New +$46.9K
HWC icon
1194
Hancock Whitney
HWC
$6.3B
$46K ﹤0.01%
1,431
-961
-40% -$29K
ODP
1195
DELISTED
ODP
ODP
$46K ﹤0.01%
1,275
+1,138
+831% +$40.3K
PMD
1196
DELISTED
Psychemedics Corporation
PMD
$46K ﹤0.01%
2,299
+1,507
+190% +$27.9K
HAYN
1197
DELISTED
Haynes International, Inc.
HAYN
$46K ﹤0.01%
1,246
-348
-22% -$13K
ABB
1198
DELISTED
ABB Ltd
ABB
$46K ﹤0.01%
2,042
-490
-19% -$10.5K
AMAG
1199
DELISTED
AMAG Pharmaceuticals
AMAG
$46K ﹤0.01%
+1,868
New +$46.7K
P
1200
DELISTED
Pandora Media Inc
P
$46K ﹤0.01%
+3,182
New +$43K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.